Statistical analyses were performed with the Mann-Whitney test
Statistical analyses were performed with the Mann-Whitney test. a murine model of recurrent bacteremia, we demonstrate that contamination with a leukocidin mutant results in increased levels of antiCantibodies compared with mice infected Safinamide with the WT parental strain, indicating that leukocidins negatively impact the generation of antiCantibodies in vivo. We hypothesized that neutralizing leukocidin-mediated immune subversion by vaccination may shift this host-pathogen conversation in favor of the host. Leukocidin-immunized mice produce potent leukocidin-neutralizing antibodies and robust Th1 and Th17 responses, which collectively protect against bloodstream infections. Altogether, these results demonstrate that blocking leukocidin-mediated immune evasion can promote host protection against bloodstream contamination. Introduction is usually a gram-positive bacterium that can cause a range of diseases, from mild skin and soft-tissue infections to life-threatening conditions such as bacteremia (Tong et al., 2015; Wertheim et al., 2005). is among the most common causes of bloodstream infections (BSIs), with a 30-d mortality rate Rabbit polyclonal to ATS2 of 20% (van Hal et al., 2012). Standard treatments for infections include active prevention (i.e., decolonization of confirmed carriers) and rigorous antibiotic treatment upon contamination (Gold and Pillai, 2009; Septimus and Schweizer, 2016). The latter approach contributes to the rise of multidrug-resistant (Chambers and Deleo, 2009). An antiCvaccine may offer a potential solution to this epidemic of antimicrobial resistance. However, identifying relevant antigens for vaccine development has proven to be challenging (Bagnoli et al., 2012; Giersing et al., 2016). To date, there is no Food and Drug AdministrationCapproved vaccine to combat infections. As such, we posit that a better understanding of how affects the development of host adaptive immunity during contamination can help to identify potential vaccine targets. has evolved to counter host defense mechanisms by producing a myriad of immune evasion factors (Foster, 2005; Thammavongsa et al., 2015). These immune evasion strategies promote bacterial survival and may contribute to the high incidence of recurrent infections (Chang et al., 2003; Creech et al., 2015; Miller et al., 2007). One such family of virulence factors is the bicomponent pore-forming toxins, also known as leukocidins (Alonzo and Torres, 2014; Spaan et al., 2017). Pathogenic strains of that infect the human host can produce and secrete up to five of these Safinamide leukocidinsLukED, the -hemolysins (HlgAB and HlgCB), Panton-Valentine leukocidin (also known as LukSF-PV), and LukAB (also known as LukGH; Alonzo and Torres, 2014; Spaan et al., 2017). Together, the leukocidins can target and kill a wide array of primary human leukocytes critical for innate immune defenses and adaptive immunity, Safinamide including neutrophils, monocytes, macrophages, dendritic cells, and effector memory T cells (Alonzo et al., 2013; Alonzo and Torres, 2014; Berends et al., 2019; DuMont et al., 2011; Reyes-Robles et al., 2013; Spaan et al., 2013, 2015, 2017). While all the leukocidins have strong tropism toward human cells, LukED and HlgAB are also active toward murine cells, thus allowing us to study the effects of these leukocidins in vivo (Alonzo et al., 2013; Lubkin et al., 2019; Reyes-Robles et al., 2013; Spaan et al., 2015, 2014). We hypothesize that this leukocidins act as immune subversion molecules that interfere with the development of adaptive immunity during contamination. Therefore, neutralizing the activity of these immune evasion molecules through vaccination can protect the host from contamination. In this study, we investigated the role of the leukocidins LukED and HlgAB in interfering with the development of adaptive immunity during BSI in mice. Our findings establish that these leukocidins can blunt the generation of antibody responses against the bacterium. However, vaccination against the leukocidins can inhibit leukocidin-mediated immune subversion and protect mice against Leukocidin-based immunizations generate both leukocidin-neutralizing antibodies and Th1/Th17 responses, which collectively protect the host against BSI. Altogether, this study demonstrates that leukocidins are crucial virulence factors employed by to counter immune defenses and that targeting leukocidin-mediated immune evasion Safinamide by vaccination leads to enhanced host-mediated protection. Results Leukocidins blunt the development of broadly neutralizing antibody responses against BSI (Alonzo et al., Safinamide 2013; DuMont et al., 2013; Lubkin et al., 2019; Reyes-Robles et al., 2013; Spaan et al., 2013, 2015, 2014). Thus, we focused on the role of LukED and HlgAB in (WT) and an isogenic strain that lacks the leukocidins LukED and HlgAB () exhibited comparable levels of bacterial burden and had similar levels of total serum IgG (Fig. S1). Recurrently infected mice developed antibodies against various secreted and surface proteins 7 d following the last contamination (Fig. 1 B). As expected, WT-infected mice developed anti-leukocidin antibodies, and mice infected with the stress didn’t develop antibodies against LukE, LukD, HlgA, and HlgB (Fig. 1 C). Anti-leukocidin antibodies isolated from WT-infected mice were shielded and practical major.